Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle

Journal of Women's Health

Volumn 9, Issue 8, 2000, Pages 857-863

  Cu Uvin, Susan ^a,h   Wright, David J ^b   Anderson, Deborah ^c   Kovacs, Andrea ^d   Watts, D Heather ^e   Cohn, Jonathan ^f   Landay, Alan ^g   Reichelderfer, Patricia S ^e  

^a BROWN UNIVERSITY   (United States)

^b WESTAT   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENSTRUAL CYCLE; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PROSPECTIVE STUDY; SERODIAGNOSIS;

ADULT; ESTRADIOL; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PROGESTERONE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0034305377     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460900750020883     Document Type: Article

References (25)

1. Valimaki M, Pelkonen R, Salaspuro M, Harkonen M, Hirvonen E, Ylikahri R. Sex hormones in amenorrheic women with alcoholic liver disease. J Clin Endocrinol Metab 1984;59:133.
2. Bierman M, Nolan GH. Menstrual function and renal transplantation. Obstet Gynecol 1977;49:186.
3. Alper MM, Garner PR. Premature ovarian failure: Its relationship to autoimmune disease. Obstet Gynecol 1985;66:27.
4. Grinspoon S, Corcoran C, Miller K, et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 1997;82:1332.
5. Chirgwin KD, Feldman J, Muneyyirci-Delale O, Landesman S, Minkoff H. Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquire Immune Defic Syndr Hum Retrovir 1996;12:489.
6. Shah PN, Smith JR, Wells C, Barton SE, Kitchen VS, Steer PJ. Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet Gynecol 1994;83:397.
7. Ellerbrock TV, Wright TC, Bush TJ, Dole P, Brudney K, Chiasson M. Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:1030.
8. Li Z, Danis V, Brooks P. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993;11:157.
9. Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998;47:290.
10. Kutteh W, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: Correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around time of ovulation. AIDS Res Hum Retrovir 1998;14:S51.
11. Szekeres-Bartho J, Par G, Szereday L, et al. Progesterone and non-specific immunologic mechanisms in pregnancy. Am J Reprod Immunol 1997;38:176.
12. Ghosh D. Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat. J Virol 1992;66:586.
13. Kolesnitchenko V, Snart RS. Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation. AIDS Res Hum Retrovir 1992;8:1997.
14. Vassiliadou N, Tucker L, Anderson DJ. Progesteroneinduced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J Immunol 1999;162:7510.
15. Lee AW, Mitra D, Laurence J. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: Implications for the prevention of maternal-fetal transmission of HIV. AIDS Res Hum Retrovir 1997;13:1235.
16. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510.
17. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside analogue therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter: AIDS Clinical Trials Group Study 175 Virologic Study. N Engl J Med 1996;335:1091.
18. Mostad SB, Overbaugh J, De Vange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922.
19. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996;2:1084.
20. Stephenson JM. Systemic review of hormonal contraception and risk of HIV transmission: When to resist meta-analysis. AIDS 1998;12:545.
21. Mostad SB, Jackson S, Overbaugh J, et al. Cervical and vaginal shedding of human immunodeficiency virus type-1 infected cells throughout the menstrual cycle. J Infect Dis 1998;178:983.
22. Greenblatt RM, Ameli N, Grant RM, Bacchetti P, Taylor RN. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. J Infect Dis 2000;181:82.
23. Goulston C, Stevens E, Gallo D, Mullins JI, Hanson CV, Katzenstein D. Human immunodeficiency virus in plasma and genital secretions during the menstrual cycle. J Infect Dis 1996;174:858.
24. Reichelderfer P, Coombs R, Wright D, Cohn J, Kovacs A. Variation in genital tract shedding of HIV RNA with the menstrual cycle. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, IL, January 31-February 4, 1999 (Abstract 225).
25. Chu SY, Hanson DL, Jones JJ, Adult/Adolescent HIV Spectrum of Disease Project Group. Pregnancy rates among women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:195.